Veracyte, Inc. (VCYT) Q1 2015 Earnings Results

Veracyte Inc Misses on Revenue, Stock Down 0.92%

Veracyte's earnings report shows a mixed performance with a loss per share that slightly exceeded expectations. However, the lack of revenue information and no guidance update contributed to a negative stock reaction, with shares falling by 0.92%. Investors may be cautious as the company navigates its growth strategy without clear financial forecasts.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.34	N/A	+2.30%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management remains focused on future opportunities despite current challenges. They emphasized their commitment to innovation.

Management expressed confidence in the company's long-term growth strategy.

They highlighted ongoing investments in research and development.

Veracyte Inc Misses on Revenue, Stock Down 0.92%

Key numbers

Management commentary

Veracyte, Inc.

More earnings this week

Veracyte Inc Misses on Revenue, Stock Down 0.92%

Key numbers

Management commentary